Opportunity
Federal Register #DEA-2026-1455
DEA Notice: Chattem Chemicals Bulk Manufacturer Registration for Controlled Substances
Buyer
Drug Enforcement Administration
Posted
August 25, 2026
Respond By
October 27, 2026
Identifier
DEA-2026-1455
NAICS
325412, 325199
This opportunity involves the Drug Enforcement Administration (DEA) announcing Chattem Chemicals' application to become a registered bulk manufacturer of multiple controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - OEM/Vendor: - Chattem Chemicals (Chattanooga, Tennessee) - Products Requested: - Bulk manufacturing registration for a wide range of controlled substances - Substances include: Gamma Hydroxybutyric Acid, Marihuana (synthetic), Tetrahydrocannabinols (synthetic), 4-Methoxyamphetamine, Dihydromorphine, Amphetamine, Methamphetamine, Lisdexamfetamine, Methylphenidate, Cocaine, Codeine, Dihydrocodeine, Oxycodone, Hydromorphone, Ecgonine, Hydrocodone, Levorphanol, Methadone, Methadone intermediate, Morphine, Oripavine, Thebaine, Oxymorphone, Noroxymorphone, Alfentanil, Remifentanil, Sufentanil, Tapentadol, Fentanyl, 3,4-Methylenedioxy-N-methylcathinone, Phenylacetone - Each substance is identified by a DEA drug code (part number) - Unique/Notable Requirements: - Registration is for bulk manufacturing only; no other activities authorized - Synthetic production specified for Marihuana and Tetrahydrocannabinols - Public comment and hearing requests are permitted before registration is finalized - No specific quantities or contract value provided - Only Chattem Chemicals is mentioned as an OEM/vendor
Description
Chattem Chemicals has applied to be registered as a bulk manufacturer of basic classes of controlled substances. The company plans to bulk manufacture the listed controlled substances to provide pharmaceutical-grade marihuana to facilitate research in compliance with local, state, and federal regulations. No other activities for these drug codes are authorized for this registration. Comments and objections can be submitted electronically or in writing on or before October 26, 2026, and a written request for a hearing can also be filed by the same date.